510(k) Report

510(k) · Cleared

Cleared

IntraMarX 3D Radiopaque Marker

K201106510(k) SpecialCleared May 21, 202027-day reviewClass II21 CFR 876.1725

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Anx Robotica Corp · FFX System, Gastrointestinal Motility (Electrical)

Cleared on May 21, 2020 as substantially equivalent to K191087 (Anx Robotica Corp, 2019) after a 27-day review. Its family tree reaches back 2 generations to 2018.

Decided
May 21, 2020
Review
27 days
Class
Class II
Product code
FFX
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K181750 (2018). No later device cites it as a predicate yet.

  1. Root · 2 generations backK181750 SitzmarksKonsyl Pharmaceuticals · 2018
  2. 1 generation backK191087 IntraMarX Radiopaque MarkersAnx Robotica Corp · 2019
  3. This deviceK201106 IntraMarX 3D Radiopaque MarkerAnx Robotica Corp · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K181750SitzmarksKonsyl Pharmaceuticals2018—
−1K191087IntraMarX Radiopaque MarkersAnx Robotica Corp2019—
0 (this device)K201106IntraMarX 3D Radiopaque MarkerAnx Robotica Corp2020—
FIG. 1 — Lineage of K201106, 2018–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FFX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FFX device

  1. #1 K262621 Rapid Barostat Bag (RBB) Pump and Catheter…score 12.4 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K191087IntraMarX Radiopaque Markers
Summary page 4
…II Classification Panel: Gastroenterology/Urology 5. Legally Marketed Predicate Device(s): Device name: IntraMarX Radiopaque Marker 510(k) number: K191087 Manufacturer: Ankon Medical Technologies (Shanghai) Co., Ltd. Page 1 of 4…
Anx Robotica Corp2019—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 2 years and passes through 2 companies; a new generation was cleared every 1.1 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All FFX devices

FFX System, Gastrointestinal Motility (Electrical): FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · FFX

1in 2025

2007: 22008: 12009: 22010: 22012: 42013: 12016: 32017: 22018: 12019: 42020: 12023: 32024: 12025: 12026 (partial year): 1
2007high 4 (2012) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FFX

123in 2023

2012: 120 days median2016: 145 days median2019: 240 days median2023: 123 days median
2007high 240 (2019) · low 120 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FFX

2so far in 2026, the most since 2007

2009: 12011: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FFX

32in 2025

2009: 22010: 62011: 62012: 42013: 42014: 42015: 102016: 152017: 102018: 172019: 272020: 202021: 262022: 312023: 512024: 592025: 32
2007high 59 (2024) · low 0 (2007)2025

MAUDE reports naming product code FFX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
20092—12
20102—06
20110—16
2012412004
20131—04
20140—04
20150—010
20163145015
20172—010
20181—017
20194240027
20201—020
20210—026
20220—031
20233123051
20241—059
20251—032
20261—2—

What is it indicated for?

IntraMarX 3D Radiopaque Markers is a diagnostic test indicated for assisting in the evaluation of colonic motility in patients with severe constipation, as diagnosed by a healthcare professional, but otherwise negative GI evaluations. For use in adult, IntraMarX 3D Radiopaque Markers is dispensed only by physicians to patients for oral intake.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K201106: IntraMarX 3D Radiopaque Marker.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K201106

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026